Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prenatal diagnosis by chorionic villus sampling.

K J Blakemore1

  • 1Department of Obstetrics and Gynecology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Obstetrics and Gynecology Clinics of North America
|June 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence of intrapartum hypoxia-ischemia is not present in the majority of cases of neonatal seizures.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2002
Same author

Pathogenesis of acardiac twinning: clues from an almost acardiac twin.

Fetal diagnosis and therapy·2002
Same author

Non-mosaic trisomy 20 presenting at 21 weeks' gestation as a thoraco-abdominal mass.

Prenatal diagnosis·2001
Same author

Cloacal outlet obstruction with an ectopic ureter.

Urology·2000
Same author

Prediction of birth weight by ultrasound in the third trimester.

Obstetrics and gynecology·2000
Same author

Molecular cytogenetic analysis and clinical findings in a newborn with prenatally diagnosed rec(7)dup(7q)inv(7)(p22q31.3)pat.

Prenatal diagnosis·1999
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Chorionic villus sampling (CVS) offers prenatal diagnosis choices, but requires more research on risks like miscarriage and infection. Further studies are needed for informed patient decisions.

Area of Science:

  • Reproductive medicine
  • Prenatal diagnostics
  • Medical genetics

Background:

  • Amniocentesis is a key prenatal diagnostic tool, especially for neural tube defects and Down syndrome.
  • Maternal serum alpha-fetoprotein screening has increased the importance of amniocentesis.
  • Patients increasingly have choices for prenatal diagnostic procedures for genetic disorders.

Purpose of the Study:

  • To evaluate the current standing and future prospects of chorionic villus sampling (CVS).
  • To identify critical areas needing further research for informed decision-making in prenatal diagnosis.

Main Methods:

  • Review of current knowledge and practices in prenatal diagnostic procedures.
  • Identification of key questions and areas of uncertainty regarding CVS risks and accuracy.

Related Experiment Videos

Main Results:

  • CVS is a chosen procedure despite remaining questions on risks and diagnostic accuracy.
  • Specific data on miscarriage rates and intrauterine infection risks from CVS are needed.
  • Maternal contamination and fetal-unrelated chromosomal mosaicism are significant concerns.

Conclusions:

  • Continued collaborative research is essential to address the uncertainties surrounding CVS.
  • Informed patient decisions regarding prenatal diagnosis depend on resolving these critical issues.
  • CVS and amniocentesis will coexist, with ongoing advancements in prenatal genetic testing.